HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians.

Abstract
Myocardial infarction (MI) is currently among the leading causes of death in the developed world. A functional SNP (rs7291467) in galectin-2 (LGALS2), a protein involved in the LTA cascade, has been associated with susceptibility to MI in the Japanese population. We explored for the first time the hypothesis that the same SNP could be associated with the risk of MI in the British population. We conducted a case-control association study on a cohort of 752 British MI patients and 705 population controls. Power calculations showed that our resource had 98% of power to detect a significant association at OR of 1.57, and 80% power to detect an association with an OR of 1.35 (recessive model). Despite this, we found no significant association of allele frequency with risk of MI. Stratification for age, gender and other cardiovascular risk factors also failed to reveal an association of this polymorphism with MI.
AuthorsMassimo Mangino, Peter Braund, Ravi Singh, Rick Steeds, John R Thompson, Kevin Channer, Nilesh J Samani
JournalAtherosclerosis (Atherosclerosis) Vol. 194 Issue 1 Pg. 112-5 (Sep 2007) ISSN: 1879-1484 [Electronic] Ireland
PMID17098239 (Publication Type: Journal Article)
Chemical References
  • Galectin 2
  • LGALS2 protein, human
Topics
  • Adult
  • Aged
  • Case-Control Studies
  • Female
  • Galectin 2 (genetics)
  • Gene Frequency
  • Genetic Predisposition to Disease (epidemiology)
  • Genetic Variation
  • Genotype
  • Humans
  • Linkage Disequilibrium
  • Male
  • Middle Aged
  • Myocardial Infarction (ethnology, genetics)
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • United Kingdom (epidemiology)
  • White People (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: